Skip to main content

Advertisement

SpringerLink
Log in

Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: A review

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The purpose of this review is to give an insight into the considerable potential of lecithin organogels (LOs) in the applications meant for topical drug delivery. LOs are clear, thermodynamically stable, viscoelastic, and biocompatible jelly-like phases, chiefly composed of hydrated phospholipids and appropriate organic liquid. These systems are currently of interest to the pharmaceutical scientist because of their structural and functional benefits. Several therapeutic agents have been formulated as LOs for their facilitated transport through topical route (for dermal or transdermal effect), with some very encouraging results. The improved topical drug delivery has mainly been attributed to the biphasic drug solubility, the desired drug partitioning, and the modification of skin barrier function by the organogel components. Being thermodynamically stable, LOs are prepared by spontaneous emulsification and therefore posses prolonged shelf life. The utility of this novel matrix as a topical vehicle has further increased owing to its very low skin irritancy potential. Varied aspects of LOs viz formation, composition, phase behavior, and characterization have been elaborated, including a general discussion on the developmental background. Besides a comprehensive update on the topical applications of lecithin organogels, the review also includes a detailed account on the mechanistics of organogelling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barr M. Percutaneous absorption.J Pharm Sci. 1962;61:395–409.

    Article  Google Scholar 

  2. Hadgraft J, Guy RH. In:Transdermal Drug Delivery: Development Issues and Research Initiatives. New York, NY: Marcel Dekker, 1989.

    Google Scholar 

  3. Asmussen B. Transdermal therapeutic systems—actual state and future developments.Methods Find Exp Clin Pharmacol. 1991;13:343–351.

    CAS  Google Scholar 

  4. Hadgraft J. Recent developments in topical and transdermal delivery.Eur J Drug Metab Pharmacokinet. 1996;21:165–173.

    Article  CAS  Google Scholar 

  5. Cevc G. Drug delivery across the skin.Expert Opin Investig Drugs. 1997;6:1887–1937.

    Article  CAS  Google Scholar 

  6. Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery.Int J Pharm. 1999;184:1–6.

    Article  CAS  Google Scholar 

  7. Mitchell DJ, Ninham BW. Micelles, vesicles and microemulsions.J Chem Soc Faraday Trans II. 1981;77:601–629.

    Article  CAS  Google Scholar 

  8. Cevc G, Paltauf E. In:Phospholipid Characterization, Metabolism and Novel Biological Applications. Champaign, IL: AOCS Press, 1995.

    Google Scholar 

  9. Attwood D, Florence AT. In:Surfactant, Systems: Their Chemistry, Pharmacy and Biology. London, UK: Chapman and Hall, 1983.

    Google Scholar 

  10. Kreuter J. In:Colloidal Drug Delivery Systems. New York, NY: Marcel Dekker, 1994.

    Google Scholar 

  11. Lawrence MJ. Surfactant systems: microemulsions and vesicles as vehicles for drug delivery.Eur J Drug Metab Pharmacokinet. 1994;19:257–269.

    Article  CAS  Google Scholar 

  12. Schwarz G. Basic kinetics of binding and incorporation with supramolecular aggregates.Biophys Chem. 1987;26:163–169.

    Article  CAS  Google Scholar 

  13. Lehn MJ. Supramolecular chemistry: scope and perspectives (Molecules, Supramolecules and Molecular devices).Angew Chem Int Ed Engl. 1988;27:89–112.

    Article  Google Scholar 

  14. Zarif L. Elongated supramolecular assemblies in drug delivery.J Control Release. 2002;81:7–23.

    Article  CAS  Google Scholar 

  15. Schmid MH, Korting HC. Liposomes: a drug carrier system for topical treatment in dermatology.Crit Rev Ther Drug Carrier Syst. 1994;11:97–118.

    CAS  Google Scholar 

  16. Abrol S, Trehan A, Katare OP. Formulation, characterization, and in vitro evaluation of silymarin loaded lipid microspheres.Drug Deliv. 2004:11:185–191.

    Article  CAS  Google Scholar 

  17. De Miguel I, Imbertie L, Rieumajou V, Major M, Kravtzoff R, Betbeder D. Proofs of the structure of lipid coated nanoparticles (SMBV) used as drug carriers.Pharm Res. 2000;17:817–824.

    Article  Google Scholar 

  18. Donatella P, Cinzia AV, Steven N, Giovanni P, Massimo, F. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability.Int J Pharm. 2002;244:21–31.

    Article  Google Scholar 

  19. Stamatis H, Xenakis A. Biocatalysts using microemulsion-based polymer gels containing lipase.J Mol Catal. B Enzym. 1999;6:399–406.

    Article  CAS  Google Scholar 

  20. Scartazzini R, Luisi PL. Organogels from lecithins.J Phys Chem. 1988;92:829–833.

    Article  CAS  Google Scholar 

  21. Schurtenberger P, Scartazzini R, Magid LJ, Leser ME, Luisi PL. Structural and dynamic properties of polymer-like reverse micelles.J Phys Chem. 1990;94:3695–3701.

    Article  CAS  Google Scholar 

  22. Capitani D, Segre AL, Dreher F, Walde P, Luisi PL. Multinuclear NMR investigation of phosphatidylcholine organogels.J Phys Chem. 1996;100:15211–15217.

    Article  CAS  Google Scholar 

  23. Walde P, Giuliani AM, Boicelli CA, Luisi PL. Phospholipid-based reverse micelles.Chem Phys Lipids. 1990;53:265–288.

    Article  CAS  Google Scholar 

  24. Shumilina EV, Khromova Y, Shchipunov YA. A study of the structure of lecithin organic gels by Fourier-transform IR spectroscopy.Zhurnal Fizicheskoi Khimii. 2000;74:1210–1219.

    CAS  Google Scholar 

  25. Cirkel P, Koper GJM. The structure of lecithin organogels.Proceedings of Conference on Colloid Chemistry: Memoriam Aladar Buzagh; September 23–26, 1996; Budapest, Hungary, Hungarian Chemical Society; 1996;36–39.

    Google Scholar 

  26. Schipunov YA. Lecithin organogel: a micellar system with unique properties.Colloids Surf A Physicochemical and Engineering Aspects. 2001;183–185:541–554.

    Article  Google Scholar 

  27. Shchipunov YA. Self-organizing structures of lecithin.Usp Khim. 1997;66:328–352.

    CAS  Google Scholar 

  28. Mezzasalma SA, Koper GJM, Shchipunov YA. Lecithin organogel as a binary blend of monodisperse polymer-like micelles.Langmuir 2000;16:10564–10565.

    Article  CAS  Google Scholar 

  29. Shchipunov YA. Lecithin organogels: rheological properties of polymer-like micelles formed in the presence of water.Colloid J. 1995;57:556–560.

    CAS  Google Scholar 

  30. Shchipunov YA, Shumilina EV. Lecithin bridging by hydrogen bonds in the organogel. In:Materials Science & Engineering C 3. 1995;43–50.

  31. Shchipunov YA, Duerrschmidt T, Hoffmann H. End-to-end fusion of polymer-like micelles in the lecithin organogel under the action of an electric field.Langmuir. 2000;16:297–299.

    Article  CAS  Google Scholar 

  32. Willimann H, Luisi PL. Lecithin organogels as matrix for transdermal transport of drugs.Biochem Biophys Res Commun. 1991;177:897–900.

    Article  CAS  Google Scholar 

  33. Willimann H, Walde P, Luisi PL, Gazzaniga A, Stroppolo F. Lecithin organogels as matrix for transdermal transport of drugs.J Pharm Sci. 1992;81:871–874.

    Article  CAS  Google Scholar 

  34. Bhatnagar S, Vyas SP. Organogel-based systems for transdermal delivery of propranolol.J Microencapsul. 1994;2:431–438.

    Article  Google Scholar 

  35. Dreher F, Walde P, Walther P, Wehrli E. Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport.J Control Release. 1997;45:131–140.

    Article  CAS  Google Scholar 

  36. Dreher F, Walde P, Luisi PL, Elsner P. Human skin irritation of a soybean lecithin microemulsion gel and of liposomes. In:Proceedings Int Symp Control Rel Bioact Mater 22 Langmuir. 1995;640–641.

  37. Dreher F, Walde P, Luisi PL, Elsner P. Human skin irritation studies of a lecithin microemulsion gel and of liposomes.Skin Pharmacol. 1996;9:124–129.

    CAS  Google Scholar 

  38. Hanahan DJ. In;A Guide to Phospholipid Chemistry. New York, NY: Oxford University Press, 1997.

    Google Scholar 

  39. Wendel A. In:Kirk-Othmer Encyclopedia of Chemical Technology. New York, NY: John Wiley & Sons, 1995;192–193.

    Google Scholar 

  40. Schneider M. Industrial production of phospholipids-lecithin processing.Lipid Technology. 1997;9:109–116.

    CAS  Google Scholar 

  41. Shumilina EV, Khromova Y, Shchipunov YA. Lecithin, organogels: the effect of phosphatidylethanolamine additives.Colloid J. 1997;59:514–518.

    CAS  Google Scholar 

  42. Moore J. Final report on the safety assessment of octyl palmitate, cetyl palmitate and isopropyl palmitate.J Am Coll Toxicol. 1982;1:13–35.

    Google Scholar 

  43. Sato K, Sugibayashi K, Morimoto Y. Effect and mode of action of aliphatic esters on the in-vitro skin permeation of micorandil.Int J Pharm. 1988;43:31–40.

    Article  CAS  Google Scholar 

  44. Arellano A, Santoyo S, Martin C, Ygartua P. Influence of propylene glycol and isopropyl myristate on in vitro percutaneous penetration of diclofenac sodium from carbopol gel.Eur J Pharm Sci. 1999;7:129–135.

    Article  CAS  Google Scholar 

  45. Parsaee S, Sarbolouki MN, Parnianpour M. In vitro release of diclofenac diethylammonium from lipid-based formulations.Int J Pharm. 2002;241:185–190.

    Article  CAS  Google Scholar 

  46. Shchipunov YA, Shumilina EV. Lecithin organogels: role of polar solvent and nature of intermolecular interactions.Colloid J. 1996;58:117–125.

    CAS  Google Scholar 

  47. Shchipunov YA, Hoffmann H. Lecithin organogels with polar additives: rheological studies.Colloid J. 1998;60:794–799.

    CAS  Google Scholar 

  48. Berti JJ, Lipskys JJ. Transcutaneous drug delivery: a practical review.Mayo Clin Proc. 1995;70:581–586.

    Article  CAS  Google Scholar 

  49. Burnham R, Gregg R, Healy P, Steadward R. The effectiveness of topical diclofenac for lateral epicondylitis.Clin J Sport Med. 1998;8:78–81.

    Article  CAS  Google Scholar 

  50. Giordano J, Daleo C, Sacks SM. Topical ondansetron attanuates nociceptive and inflammatory effects of intradermal capsaicin in humans.Eur J Pharmacol. 1998;354:R13-R14.

    Article  CAS  Google Scholar 

  51. Crandall WT, inventor.Topical moisturizing composition and method. US Patent 6 316 428. November 13, 2001.

  52. Collett JH, Popli H, Kibbe AH, ed. Poloxamer. In:Handbook of Pharmaceutical Excipients. 3rd ed. London, UK: Pharmaceutical Press, 2000;386–388.

    Google Scholar 

  53. Shchipunov YA, Schmiedel P. Phase behavior of lecithin at the oil/water interface.Langmuir. 1996;12:6443–6445.

    Article  CAS  Google Scholar 

  54. Shchipunov YA, Schmiedel P. Electrorheological phenomena in lecithin-decane-water mixtures.J Colloid Interface Sci. 1996;179:201–206.

    Article  CAS  Google Scholar 

  55. Shchipunov YA, Hoffmann H. Growth, branching and local ordering of lecithin polymer-like micelles.Langmuir. 1998;14:6350–6360.

    Article  CAS  Google Scholar 

  56. Shchipunov YA, Shumilina EV, Ulbricht W, Hoffmann H. The branching of reversed polymer-like micelles of lecithin by sugar-containing surfactants.J Colloid Interface Sci. 1999;211:81–88.

    Article  CAS  Google Scholar 

  57. Shchipunov YA, Durrschmidt T, Hoffmann H. Electrorheological effects in lecithin organogels with water and glycerol.J Colloid Interface Sci. 1999;212:390–401.

    Article  CAS  Google Scholar 

  58. Shchipunov YA, Shumilina EV, Hoffmann H. Lecithin organogels with alkylglucosides.J Colloid Interface Sci. 1998;199:218–221.

    Article  CAS  Google Scholar 

  59. Shchipunov YA, Shumilina EV, Hoffmann H. Lecithin organogels with n-alkyl-D-glycosides and n-alkyl-D-lactobionamide.Colloid Polym Sci. 1998;276:368–372.

    Article  CAS  Google Scholar 

  60. Shchipunov YA, Hoffmann H. Thinning and thickening effects induced by shearing in lecithin solutions of polymer-like micelles.Rheologica Acta. 2000;39:542–553.

    Article  CAS  Google Scholar 

  61. Voit AV, Shchipunov YA. Dynamics of polymer-like lecithin micelles—rheological measurements.Colloid J. 2000;62:424–430.

    CAS  Google Scholar 

  62. Shchipunov YA, Mezzasalma SA, Koper GJM, Hoffmann H. Lecithin organogel with new rheological and scaling behavior.J Phys Chem B. 2001;105:10484–10488.

    Article  CAS  Google Scholar 

  63. Israelachvili JN, Mitchell DJ, Ninham BW. Theory of self assembly of hydrocarbon amphiphiles into micelles and bilayers.J Chem Soc Faraday Trans II. 1976;72:1525–1568.

    Article  Google Scholar 

  64. Seddon JM. Structure of the inverted hexagonal (H11) phase and non-lamellar phase transitions of lipids.Biochim Biophys Acta. 1990;1031:1–69.

    CAS  Google Scholar 

  65. Suzuki M, Nakajima Y, Yumoto M, Kimura M, Shirai H, Hanabusa K. In situ organogelation at room temperature: direct synthesis of gelators in organic solvents.Org Biomol Chem. 2004;2:1155–1159.

    Article  CAS  Google Scholar 

  66. Schurtenberger P, Peng Q, Leser ME, Luisi PL. Structure and phase behaviour of lecithin-based microemulsions: a study of chain length dependence.J Colloid Interface Sci. 1993;156:43–51.

    Article  CAS  Google Scholar 

  67. Shioi A, Harada M, Tanabe M. Static light scattering from oil-rich microemulsions containing polydispersed cylindrical aggregates in sodium bis(2-ethylhexyl) phosphate system.J Phys Chem. 1995;99:4750–4756.

    Article  CAS  Google Scholar 

  68. Aboofazeli R, Barlow DJ, Lawrence MJ. Particle size analysis of concentrated phospholipid microemulsions. I. Total intensity light scattering.AAPS PharmSci. 2000;2:E13.

    Article  CAS  Google Scholar 

  69. Zemb TN, Barnes IS, Derian PJ, Ninham BW. Scattering as a critical test of microemulsion structural models.Prog Colloid Polym Sci. 1990;81:20–29.

    CAS  Google Scholar 

  70. Terech P, Weiss RG. Low molecular mass gelators of organic liquids and the properties of their gels.Chem Rev. 1997;97:3133–3159.

    Article  CAS  Google Scholar 

  71. Simmons BA, Taylor CE, Landis FA, McPherson GL, Schwartz DK, Moore R. Microstructure determination of AOT+Phenol organogels utilizing small-angle X-ray scattering and atomic force microscopy.J Am Chem Soc. 2001;123:2414–2421.

    Article  CAS  Google Scholar 

  72. Gronwald O, Snip E, Shinkai S. Gelators for organic liquids based on self-assembly: a new facet of supramolecular and combinatorial chemistry.Curr Opinion Colloid Interface Sci. 2002;7:148–156.

    Article  CAS  Google Scholar 

  73. Abdallah DJ, Sirchio SA, Weiss RG. Hexatriacontane organogels. The first determination of the conformation and molecular packing of a low-molecular mass organogelator in its gelled state.Langmuir. 2000;16:7558–7561.

    Article  CAS  Google Scholar 

  74. van Esch JH, Feringa BL. New functional materials based on self-assembling organogels: from serendipity towards design.Angew Chem Int Ed Engl. 2000;39:2263–2266.

    Article  Google Scholar 

  75. McAllister K, Sazani P, Adam M, et al. Polymeric nanogels produced via inverse microemulsion polymerization as potential gene and antisense delivery agents.J Am Chem Soc. 2002;124:15198–15207.

    Article  CAS  Google Scholar 

  76. Schurtenberger P, Scartazzini R, Luisi PL. Viscoelastic properties of polymerlike reverse micelles.Rheologica Acta. 1989;28:372–381.

    Article  CAS  Google Scholar 

  77. Jibry N, Heenan RK, Murdan S. Amphiphilogels for drug delivery: formulation and characterization.Pharm Res. 2004;21:1852–1861.

    Article  CAS  Google Scholar 

  78. Terech P. Kinetics of aggregation in steroid derivative/cyclohexane gelifying system.J Colloid Interface Sci. 1985;107:244–255.

    Article  CAS  Google Scholar 

  79. Couffin-Hoarau A-C, Motulsky A, Delmas P, Leroux J-C.In situ-forming pharmaceutical organogels based on the self-assembly of L-Alanine derivatives.Pharm Res. 2004;21:454–457.

    Article  CAS  Google Scholar 

  80. Nastruzzi C, Gambari R. Antitumor activity of (trans)dermally delivered aromatic tetra-amidines.J Control Release. 1994;29:53–62.

    Article  CAS  Google Scholar 

  81. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems.Adv Drug Deliv Rev. 2000;45:89–121.

    Article  CAS  Google Scholar 

  82. Charles L, Matthew D, inventors.Cardiac glycosides for treating muscle pain and spasm. US patent appl publ 20030229029. December 11, 2003.

  83. Friedman M, inventor,Treatment of bruxism. US patent 6 632 843. October 14, 2003.

  84. Crandall WT, inventor.Method for topical treatment of scars with protein kinase C inhibitors. US patent 6 306 383. October 23, 2001.

  85. Crandall WT, inventor,Method for topical treatment of carpal tunnel syndrome. US patent appl publ 20020164389. November 7, 2002.

  86. Padilla M, Clark GT, Merill RL. Topical medications for orofacial pain: a review.J Am Dent Assoc. 2000;131:184–195.

    CAS  Google Scholar 

  87. Ford PR, inventor.Topical pain relief composition and carrier. US patent appl publ 20020028789. March 7, 2002.

  88. Archer HK, Pettit MS, inventors. Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery. PCT Int Appl WO2000045796. February 4, 2000.

  89. Flores JA, Crowley KL, inventors.Process for the preparation of ketamine ointment. US patent 5 817 699. October 6, 1998.

  90. Crandall WT, inventor.Composition and method for topical treatment of androgenic alopecia. US patent appl publ 20030049336. March 13, 2003.

  91. Crandall WT, inventor.Transdermal transport of molecules. PCT Int Appl WO9803641. January 29, 1998.

  92. Grace D, Rogers J, Skeith K, Anderson K. Topical diclofenac versus placebo: a double blind, randomized, clinical trial in patients with osteoarthritis of the knee.J Rheumatol. 1999;26:2659–2663.

    CAS  Google Scholar 

  93. Shippen E. Progesterone organogel for premenstrual dysphoric disorder.J Am Acad Child Adolesc Psychiatry. 2001;40:262–263.

    Article  CAS  Google Scholar 

  94. Kryger A, inventor. Topical testosterone formulations. PCT Int Appl WO2002055020. July 18, 2002.

  95. Ciribassi JL, Luescher A, Pasloske KS, Robertson-Plouch C, Zimmerman A, Kaloostian-Whittymore L. Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats.Am J Vet Res. 2003;64:994–998.

    Article  CAS  Google Scholar 

  96. Aboofazeli RZ, Zia H, Needham TE. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.Drug Deliv. 2002;9:239–247.

    Article  CAS  Google Scholar 

  97. Hoffman SB, Yoder AR, Trepanier LA. Biovailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats.J Vet Pharmacol Ther. 2002;25:189–193.

    Article  CAS  Google Scholar 

  98. Bonina FP, Montenegro L, Scrofani N, et al. Effects of phospholipids based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate.J Control Release. 1995;34:53–63.

    Article  CAS  Google Scholar 

  99. Agrawal GP, Juneja M, Agrawal S, Jain SK, Pancholi SS. Preparation and characterization of reverse micelle based organogels of piroxicam.Pharmazie. 2004;59:191–193.

    CAS  Google Scholar 

  100. Cadden B. Pharmaceutical compounding in pain medicine.NEPA Newsletter. 2000. Available at: http://www.ampainsoc.org/societies/nepa/newsl_winter00.htm. Accessed: 26 July, 2004

  101. Stafford Pharmacy and Home Healthcare. Information on natural hormone replacement therapy. 2003. Available at: http://www.stafford-pharmacy.com/NHRT.htm. Accessed: 26 July, 2004

  102. Maxima Pharmaceuticals Inc. DiffusiMax and DiffusiMax Kit [Product Manual]. 2002. Edmonton, Canada: Maxima Pharmaceuticals Inc. Available at: http://www.maximapharmaceuticals.com/maximal/pdf/WebReady_En_CM_052003.pdf. Accessed: 26 July, 2004

  103. J. A. R. Pharmaceuticals Limited. Phlojel and Phlojel Ultra. 2003. Edmonton, Canada: J.A.R. Pharmaceuticals Ltd. Available at: http://www.phlojel.com. Accessed: 26 July, 2004

  104. Drugs-r-us.org. Speciality treatments. 2004. Available at: http://www.drugs-r-us.org/treatments.html. Accessed: 26 July, 2004

  105. Reed’s RX Compounding Pharmacy Web site. Transdermal gels. 2004. Available at: http://www.Reedsrx.com/compounding/gel.htm. Accessed: 26 July, 2004.

Download references

Author information

Authors and Affiliations

  1. University Institute of Pharmaceutical Sciences, Panjab University Campus, Sector-14, Chandigarh, India

    Rajiv Kumar & Om Prakash Katare

Authors
  1. Rajiv Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Om Prakash Katare
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Om Prakash Katare.

Additional information

Published: October 6, 2005

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kumar, R., Katare, O.P. Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: A review. AAPS PharmSciTech 6, 40 (2005). https://doi.org/10.1208/pt060240

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt060240

Keywords

Search

Navigation